KNSA · Company research
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals (NASDAQ:KNSA): Affordable Growth Backed by Accelerating Earnings - ChartMill | Kiniksa Pharmaceuticals (NASDAQ:KNSA): Affordable Growth Backed by Accelerating Earnings ChartMill | View source ↗ | ChartMill | Oct 2, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment (NASDAQ:KNSA) - Seeking Alpha | Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment (NASDAQ:KNSA) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 2, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat | Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Coverage Initiated by Analysts at Wells Fargo & Company MarketBeat | View source ↗ | MarketBeat | Sep 30, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock Has Consensus Price Target of $87.38 According to Brokerages - MarketBeat | Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock Has Consensus Price Target of $87.38 According to Brokerages MarketBeat | View source ↗ | MarketBeat | Sep 25, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines High Growth Momentum with a Breakout Setup - ChartMill | Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines High Growth Momentum with a Breakout Setup ChartMill | View source ↗ | ChartMill | Aug 29, 2026 | neutral | 0 | 0.6 |
| $KNSA stock is up 21% today. Here's what we see in our data. - Quiver Quantitative | $KNSA stock is up 21% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 28, 2026 | neutral | 0 | 0.6 |
| KNSA Stock Jumps As Wall Street Boosts Price Targets - StocksToTrade | KNSA Stock Jumps As Wall Street Boosts Price Targets StocksToTrade | View source ↗ | StocksToTrade | Jul 28, 2026 | neutral | 0 | 0.6 |
| KNSA Stock Jumps As Wall Street Hikes Price Targets - Timothy Sykes | KNSA Stock Jumps As Wall Street Hikes Price Targets Timothy Sykes | View source ↗ | Timothy Sykes | Jul 28, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals International, plc (KNSA) Q2 Earnings Match Estimates - Yahoo Finance | Kiniksa Pharmaceuticals International, plc (KNSA) Q2 Earnings Match Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Jul 28, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) Growth Stock Surges on Revenue Beat and Raised Guidance - ChartMill | Kiniksa Pharmaceuticals (NASDAQ:KNSA) Growth Stock Surges on Revenue Beat and Raised Guidance ChartMill | View source ↗ | ChartMill | Jul 28, 2026 | neutral | 0 | 0.6 |
| Kiniksa stock rises after Q2 beat on Arcalyst (KNSA:NASDAQ) - Seeking Alpha | Kiniksa stock rises after Q2 beat on Arcalyst (KNSA:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 28, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) Qualifies as an Affordable Growth Stock With Strong Revenue and Earnings Momentum - ChartMill | Kiniksa Pharmaceuticals (NASDAQ:KNSA) Qualifies as an Affordable Growth Stock With Strong Revenue and Earnings Momentum ChartMill | View source ↗ | ChartMill | Jul 21, 2026 | neutral | 0 | 0.6 |
| Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In? - Yahoo Finance | Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 9, 2026 | neutral | 0 | 0.6 |
| What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now? - Yahoo Finance | What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| KNSA Forecast — Price Target — Prediction for 2027 - TradingView | KNSA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Stock Of The Day In Buy Zone, Leads Industry Despite Supersmall Market - Investor's Business Daily | Stock Of The Day In Buy Zone, Leads Industry Despite Supersmall Market Investor's Business Daily | View source ↗ | Investor's Business Daily | Jun 4, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.